Balancing on a knife's edge: evidence-based medicine and the marketing of health technology

Affiliations

Editorial

Søren M Bentzen et al. Int J Radiat Oncol Biol Phys. 2008.

. 2008 Sep 1;72(1):12-4; discussion 14-8.

doi: 10.1016/j.ijrobp.2008.05.044.

¹ Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

No abstract available

Comment in

Hypofractionation, long-term effects, and the alpha/beta ratio.
Glatstein E. Glatstein E. Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):11-2. doi: 10.1016/j.ijrobp.2008.07.006. Int J Radiat Oncol Biol Phys. 2008. PMID: 18722259 No abstract available.
Assessment of technological advances in radiation oncology: from whence comes the funding?
Cox JD. Cox JD. Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):11. doi: 10.1016/j.ijrobp.2008.07.007. Int J Radiat Oncol Biol Phys. 2008. PMID: 18722260 No abstract available.
Balancing on a knife's edge: evidence-based medicine and the marketing of health technology. In regard to Bentzen et al. (Int J Radiat Oncol Biol Phys 2008;72:12-14).
Fuller DB. Fuller DB. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):637-8. doi: 10.1016/j.ijrobp.2008.10.003. Int J Radiat Oncol Biol Phys. 2009. PMID: 19147029 No abstract available.